Who
Lauren Rusckowski Duprey
Chief Transformation Officer
Company insider
Files Form 4 as: Chief Transformation Officer, Takeda Pharmaceutical Company.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $2.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Apr 2026
- Last trade
- 14 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Sep 2026filed 15 Sep 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $640K34,535 at $18.54 | filing |
| 14 Sep 2026filed 15 Sep 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $640K34,535 at $18.54 | filing |
| 10 Aug 2026filed 12 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $814K47,586 at $17.10 | filing |
| 10 Aug 2026filed 12 Aug 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Sold | $814K47,586 at $17.10 | filing |
| 1 Jul 2026filed 6 Jul 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —45,140 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —45,140 at $0.00 | filing |
| 27 Apr 2026filed 28 Apr 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —59,990 at $0.00 | filing |
| 27 Apr 2026filed 28 Apr 2026 | TAK Takeda Pharmaceutical CompanyPharmaceuticals | SEC FORM 4 Code A | —59,990 at $0.00 | filing |
News
Takeda Pharmaceutical (NYSE:TAK) Insider Lauren Rusckowski Duprey Sells 34,535 Shares of Stocktickerreport.com · 16 Sep 2026
1 headline in the last 90 days name Lauren Rusckowski Duprey; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.